In a syngeneic immunocompetent model, mice treated with murine meso.CAR-T had little tumor control but when combined with non-replicating Ad vectors expressing murine IL-2 and TNFa complete short-term tumor inhibition was achieved. Here, TNF is linked to neoplasm.